Interestingly, a splice variant of VEGF-R2 encoding for a soluble form of the receptor did not affect tumor angiogenesis but blocked lymphangiogenesis presumably due to the ability of soluble VEGF-R2 to bind VEGF-C [65]. Here, VEGFC is linked to neoplasm.